Up next

Autoplay

Expert Insights Into Amyloidosis: The Systemic Amyloidoses vs Parkinson's vs Alzheimer's

0 Views • 06/06/25
Share
Embed
administrator
administrator
Subscribers
0

Current medical education on amyloid diseases is 25 years old and materially outdated, punctuated by rapid advancement in the last five years. Hear from renowned Dr. Jeff Kelly from Scripps Research, developer of ATTR drug Tafamidis, about the current biology and how amyloid diseases such as the Systemic Amyloidoses (ATTR and AL), Parkinson’s and Alzheimer's are today believed to be more similar than different.

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay